{
    "paper_id": "0b64a4383fc6b1e04c202a4fa27f0c634c9daf45",
    "metadata": {
        "title": "Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines",
        "authors": [
            {
                "first": "Lin",
                "middle": [],
                "last": "Ang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hye",
                "middle": [
                    "Won"
                ],
                "last": "Lee",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jun",
                "middle": [
                    "Yong"
                ],
                "last": "Choi",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Pusan National University",
                    "location": {
                        "settlement": "Busan",
                        "country": "Republic of Korea"
                    }
                },
                "email": ""
            },
            {
                "first": "Junhua",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Tianjin University of Traditional Chinese Medicine",
                    "location": {
                        "settlement": "Tianjin",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Soo",
                "middle": [],
                "last": "Lee",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Background:: Coronavirus disease 2019 is pandemic and has caused illness to many people worldwide. This review aimed to summarize and analyze the herbal formulae provided by the guidelines for their pattern identifications (PIs) and compositions of herbs to treat patients with COVID-19. Methods:: We searched 7 data sources for eligible traditional medicine guidelines up to March 6, 2020 and found a total of 28 traditional medicine guidelines that provide treatment measures for COVID-19. Results:: Of the 28 guidelines, there were 26 government-issued Chinese guidelines and 2 Korean guidelines. After standardizing the terminology of the PIs and herbal formulae, there were 8 PIs and 23 herbal formulae for the mild stage, 11 PIs and 31 herbal formulae for the moderate stage, 8 PIs and 21 herbal formulae for the severe stage, and 6 PIs and 23 herbal formulae for the recovery stage in the Chinese guidelines. In the Korean guidelines, there were 4 PIs and 15 herbal formulae for the mild stage, 3 PIs and 3 herbal formulae for the severe stage, and 2 PIs and 2 herbal formulae for the recovery stage. In the frequency analysis of herbs, Glycyrrhizae Radix et Rhizoma was found to be the herb with the highest frequency of usage in the Chinese guidelines. Conclusion:: This review can be used as guidance for the traditional medicine treatment of COVID-19. Clinical evidence is needed in the future to evaluate the efficacy of traditional medicine.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Coronavirus disease 2019 (COVID-19) is a newly identified strain of coronavirus that causes illness ranging from effects similar to the common cold to fatal diseases in people across the world. 1 This disease was first identified in early December 2019, and by the middle of March 2020, the World Health Organization (WHO) assessed COVID-19 as a pandemic. 2 As of March 2020, there have been more than 178,700 confirmed cases in at least 140 countries. The majority of cases were reported in mainland China, followed by Italy, Iran, Spain and South Korea. 3 on prevention method but not treatment methods. Therefore, we aimed to systematically analyze the herbal formulae in the guidelines for pattern identifications and herbal compositions recommended for treating patients with COVID-19.",
            "cite_spans": [
                {
                    "start": 194,
                    "end": 195,
                    "text": "1",
                    "ref_id": null
                },
                {
                    "start": 356,
                    "end": 357,
                    "text": "2",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 556,
                    "end": 557,
                    "text": "3",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "The following data sources were searched on February 25, 2020 for eligible traditional medicine guidelines and searched up to March 6 to retrieve the updated version of the guidelines provided:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data sources"
        },
        {
            "text": "\u2022 Guidelines International Network (G-I-N) 8 \u2022 \"Chinese guidelines on Novel Coronavirus\" resources 9 by Evidence Aid ",
            "cite_spans": [
                {
                    "start": 43,
                    "end": 44,
                    "text": "8",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [],
            "section": "Data sources"
        },
        {
            "text": "This study focused on the recommended treatment modalities related to traditional medicine for COVID-19. All guidelines that provide traditional medicine treatment measures were included regardless of language, and publication types and years. Guidelines that only provide preventive measures without treatment measures were excluded.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Inclusion and exclusion criteria"
        },
        {
            "text": "Herbal formulae related to folk medicine were excluded only and other herbal formulae in these guidelines were included. As the guidelines were outlined based on regional characteristics, regional folk medicines, such as Tibetan medicine in Tibet, Mongolian medicine in Inner Mongolia, and Miao medicine in Guizhou province, were integrated into their guidelines.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Inclusion and exclusion criteria"
        },
        {
            "text": "The data from each included guideline were extracted using a predefined data extraction table. The content of the data extraction tables comprised the stages of the disease, pattern identification, clinical symptoms, therapeutic principle, name and composition of herbal formulae, amount of herbs, and country or province of the provided guideline. The pattern identification and herbal formulae were analyzed according to the severity of the disease (mild, moderate, severe and recovered stages). The frequency of herbs recommended in the herbal formulae for each stage of disease was also computed and analyzed.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data extraction and analyses"
        },
        {
            "text": "The terminology of pattern identification were standardized based on the clinical manifestation provided in the guidelines and Clinic Terminology of Traditional Chinese Medical Diagnosis and Treatment-Syndromes. 13 The herbal formulae with missing names were also renamed by comparing the compositions of these herbal formulae with other named herbal formulae and doublechecked them with the Dictionary of Traditional Chinese Medicine Formula. 14 All the terminologies were also standardized based on the WHO international standard terminologies for traditional medicine. 15 ",
            "cite_spans": [
                {
                    "start": 212,
                    "end": 214,
                    "text": "13",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 444,
                    "end": 446,
                    "text": "14",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 572,
                    "end": 574,
                    "text": "15",
                    "ref_id": "BIBREF17"
                }
            ],
            "ref_spans": [],
            "section": "Terminology standardization"
        },
        {
            "text": "A total of 28 traditional medicine guidelines that provide treatment measures for COVID-19 were found. Of the 28 guidelines, there were 26 government-issued Chinese guidelines and 2 Korean medicine-professional associations-issued Korean guidelines. The Japanese government did not officially issue any traditional medicine guidelines on COVID-19, but they adopted a translated version of the national guideline issued by the National Health Commission of China.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Results"
        },
        {
            "text": "In mainland China, there are currently 7 versions of national diagnosis and treatment guidelines, and traditional medicine content has been included since the third version. 6 Using the government-issued national guidelines as a reference, 17 provinces, 4 municipalities and 4 autonomous regions in mainland China officially issued traditional medicine-related guidelines for the prevention and treatment of COVID-19. All the guidelines were devised by local health authorities according to regional characteristics and local prevalence of COVID-19 and have been continuously updated since the first issuance. 5 In Korea, the Association of Korean Medicine and the Korean Association of Traditional Pulmonary Medicine each issued the first version of traditional medicine guidelines on the prevention and treatment of COVID-19 at the end of February 2020. 7 Both guidelines were drafted by clinical experts who were also regularly updated by both associations to provide clinical guidance for the prevention and treatment of COVID-19 in South Korea.",
            "cite_spans": [
                {
                    "start": 174,
                    "end": 175,
                    "text": "6",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 610,
                    "end": 611,
                    "text": "5",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 856,
                    "end": 857,
                    "text": "7",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "Results"
        },
        {
            "text": "In the frequency analysis of the herbs used in the herbal formulae for treating patients with COVID-19 according to the patients' disease stages and PIs (Tables 1-5) , the results showed that there were 8 PIs and 23 herbal formulae for the mild stage (Table 1) ; 11 PIs and 31 herbal formulae for the moderate stage ( Table 2) ; 8 PIs and 21 herbal formulae for the severe stage (Table 3) ; and 6 PIs and 23 herbal formulae for the recovery stage (Table 4) in the Chinese guidelines. The Korean guidelines suggested 4 PIs and 15 herbal formulae for the mild stage, 3 PIs and 3 herbal formulae for the severe stage, and 2 PIs and 2 herbal formulae for the recovery stage (Table 5) .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 153,
                    "end": 165,
                    "text": "(Tables 1-5)",
                    "ref_id": "TABREF8"
                },
                {
                    "start": 251,
                    "end": 260,
                    "text": "(Table 1)",
                    "ref_id": null
                },
                {
                    "start": 318,
                    "end": 326,
                    "text": "Table 2)",
                    "ref_id": "TABREF1"
                },
                {
                    "start": 379,
                    "end": 388,
                    "text": "(Table 3)",
                    "ref_id": "TABREF3"
                },
                {
                    "start": 447,
                    "end": 456,
                    "text": "(Table 4)",
                    "ref_id": "TABREF5"
                },
                {
                    "start": 670,
                    "end": 679,
                    "text": "(Table 5)",
                    "ref_id": "TABREF8"
                }
            ],
            "section": "Results"
        },
        {
            "text": "Among the Chinese guidelines, we also found that most of the herbal formulae were recommended once in the respective guidelines. However, 17 herbal formulae were recommended several times by different guidelines, with a slight difference in the herbal compositions. The herbal formulae with the highest frequency of recommendation were the herbal formula of Shen Fu Tang with Su He Xiang Pill or Angong Niuhuang Pill in the severe stage and the combined formula of Xiang Sha Liu Junzi Tang and Li Zhong Pill in the recovery stage. In particular, Angong Niuhuang Pill, Zhi Bao Dan, Zi Xue San, and Su He Xiang Pill were the only prescriptions that were not required in the form of decoction and were only prescribed in the severe stage.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Results"
        },
        {
            "text": "On the other hand, the herbal formula of Qingfei Paidu Tang, which is a combination of 4 different herbal formulae with 21 herbs (Tables 1-4) , was recommended by the Chinese national diagnosis and treatment guidelines in the treatment of COVID-19 regardless of disease stage or regional status. This herbal formula was also recommended for the treatment of severe stage in the Korean guidelines (Table 5 ).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 129,
                    "end": 141,
                    "text": "(Tables 1-4)",
                    "ref_id": "TABREF5"
                },
                {
                    "start": 396,
                    "end": 404,
                    "text": "(Table 5",
                    "ref_id": "TABREF8"
                }
            ],
            "section": "Results"
        },
        {
            "text": "In addition, the frequency of the herbs used in the herbal formulae recommended by the Chinese guidelines for every stage and in total were computed (Fig. 1) . The results showed that these formulae contain 12 herbs with a frequency of use 30 or more times in the treatment formulae in all stages. Both Armeniacae Semen Table 1  Herbal Medicines and Pattern Identification for Treating Mild Stage Patients With COVID-19 Ephedrae Herba 5-10 g, Armeniacae Semen Amarum 5-10 g, Amomi Tsao-ko Fructus 5-10 g, Arecae Semen 5-10 g, Cicadae Periostracum 6-12 g, Forsythiae Fructus 10-20 g, Atractylodis Rhizoma 10-20 g, Scutellariae Radix 10-15 g, Coicis Semen 10-15 g, Glycyrrhizae Radix et Ephedrae Herba 6 g, Armeniacae Semen Amarum 9 g, Coicis Semen 18 g, Amomi Fructus Rotundus 9 g, Agastachis Herba 9 g, Magnoliae Officinalis Cortex 12 g, Pinelliae Rhizoma Praeparatum cum alumine 9 g, Poria Sclerotium 12 g, Polyporus 9 g, Scutellariae Radix 9 g, Forsythiae Fructus 12 g, Glycyrrhizae Radix et Rhizoma Qingfei Paidu Tang Ephedrae Herba 9 g, Glycyrrhizae Radix et Rhizoma 6 g, Armeniacae Semen Amarum 9 g, Gypsum Fibrosum 15-30 g, Cinnamomi Ramulus 9 g, Alismatis Rhizoma 9 g, Polyporus 9 g, Atractylodis Macrocephalae Rhizoma 9 g, Poria Sclerotium 15 g, Bupleuri Radix16g, Scutellariae Radix 6 g, Pinelliae Rhizoma 9 g, Zingiberis Rhizoma Recens 9 g, Asteris Radix 9 g, Farfare Flos 9 g, Belamcandae Rhizoma 9 g, Asari Herba 6 g, Dioscoreae Rhizoma 12 g, Aurantii Fructus 6 g, Citri Unshius Pericarpium 6 g, Agastachis Herba 9 g a Name of the herbal formula is originally not reported, and the authors named them based on Dictionary of Traditional Chinese Medicine Formula. Scutellariae Radix 15 g, Anemarrhenae Rhizoma 10 g, Ephedrae Herba 10 g, Armeniacae Semen Amarum 9 g, Amomi Fructus Rotundus 6 g, Coicis Semen 30 g, Mori Radicis Cortex 15 g, Atractylodis Rhizoma 10 g, Astragali Radix 10 g, Lepidii seu Descurainiae Semen 15 g Ma Xing Shi Gan Tang + Qianjing Weijing Tang Ephedrae Herba 9 g, Armeniacae Semen Amarum 10 g, Gypsum Fibrosum 30 g, Anemarrhenae Rhizoma 12 g, Poria Sclerotium 10 g, Phragmitis Rhizoma 30 g, Oryzae Semen 30 g, Benincasae Pericarpium 30 g, Persicae Semen 12 g, Fagopyri Radix 30 g, Scutellariae Radix 12 g, Platycodonis Radix 9 g, Pinelliae Rhizoma 9 g, Perillae Caulis 12 g, Sappan Lignum 12 g Qingqi Huatan Tang Qingfei Paidu Tang Ephedrae Herba 9 g, Glycyrrhizae Radix et Rhizoma 6 g, Armeniacae Semen Amarum 9 g, Gypsum Fibrosum 15-30 g, Cinnamomi Ramulus 9 g, Alismatis Rhizoma 9 g, Polyporus 9 g, Atractylodis Macrocephalae Rhizoma 9 g, Poria Sclerotium 15 g, Bupleuri Radix16g, Scutellariae Radix 6 g, Pinelliae Rhizoma 9 g, Zingiberis Rhizoma Recens 9 g, Asteris Radix 9 g, Farfare Flos 9 g, Belamcandae Rhizoma 9 g, Asari Herba 6 g, Dioscoreae Rhizoma 12 g, Aurantii Fructus 6 g, Citri Unshius Pericarpium 6 g, Agastachis Herba 9 g a Name of the herbal formula is originally not reported, and the authors named them based on Dictionary of Traditional Chinese Medicine Formula. 1. Adenophorae Radix 10 g, Glehniae Radix 10 g, Ophiopogonis Radix 15 g, Panacis Quinquefolii Radix 6 g, Schisandrae Fructus 6 g, Gypsum Fibrosum 15 g, Lophatheri Herba 10 g, Mori Folium 10 g, Phragmitis Rhizoma 15 g, Salviae Miltiorrhizae Radix 15 g, Glycyrrhizae Radix et Rhizoma 6 g a 2. Adenophorae Radix 15 g, Ginseng Radix 9 g, Codonopsis Radix 9 g, Pseudostellariae Radix 15 g, Ginseng Radix 9 g, Panacis Quinquefolii Radix 9 g, Asparagi Radix 9 g, Ophiopogonis Radix 9 g, Lophatheri Herba 9 g, Mori Folium 9 g, Cicadae Periostracum 6 g, Lycii Cortex 9 g, Atractylodis Rhizoma Astragali Radix praeparata cum melle 30 g, Amomi Fructus 6 g, Codonopsis Radix 15 g, Poria Sclerotium 15 g, Citri Reticulatae Pericarpium 10 g, Pinelliae Rhizoma 9 g, Agastachis Herba 10 g Xiang Sha Liu Junzi Tang + Li Zhong Pill 1. Pinelliae Rhizoma Praeparatum 9 g, Citri Reticulatae Pericarpium 10 g, Codonopsis Radix 15 g, Astragali Radix praeparata cum melle 30 g, Poria Sclerotium 15 g, Agastachis Herba 10 g, Amomi Fructus 6 g a 2. Citri Reticulatae Pericarpium 10 g, Codonopsis Radix 15 g, Astragali Radix praeparata cum melle 30 g, Poria Sclerotium 15 g, Agastachis Herba 10 g, Amomi Fructus 6 g a 3. Pinelliae Rhizoma Praeparatum 9 g, Citri Reticulatae Pericarpium 10 g, Codonopsis Radix 15 g, Astragali Radix praeparata cum melle 30 g, Atractylodis Macrocephalae Rhizoma 10 g, Poria Sclerotium 15 g, Agastachis Herba 10 g, Amomi Fructus 6 g, Glycyrrhizae Radix et Rhizoma 6 g Astragali Radix 18 g, Codonopsis Radix 9 g, Poria Sclerotium 15 g, Atractylodis Macrocephalae Rhizoma 12 g, Pinelliae Rhizoma Praeparatum 9 g, Paeoniae Radix Alba 9 g, Lophatheri Herba 6 g, Alismatis Rhizoma 12 g, Angelicae Pubescentis Radix 9 g, Notopterygii Rhizoma seu Radix 9 g, Bupleuri Radix 9 g, Scrophulariae Radix 12 g, Trichosanthis Radix 12 g, Glycyrrhizae Radix et Rhizoma 6 g Qingfei Paidu Tang Ephedrae Herba 9 g, Glycyrrhizae Radix et Rhizoma 6 g, Armeniacae Amarum Semen 9 g, Gypsum Fibrosum 15\u223c30 g, Cinnamomi Ramulus 9 g, Alismatis Rhizoma 9 g, Polyporus 9 g, Atractylodis Macrocephalae Rhizoma 9 g, Poria Sclerotium 15 g, Bupleuri Radix16g, Scutellariae Radix 6 g, Pinelliae Rhizoma 9 g, Zingiberis Rhizoma Recens 9 g, Asteris Radix 9 g, Farfare Flos 9 g, Belamcandae Rhizoma 9 g, Asari Herba 6 g, Dioscoreae Rhizoma 12 g, Aurantii Fructus 6 g, Citri Unshius Pericarpium 6 g, Agastachis Herba 9 g Osterici Radix 6 g, Saposhnikoviae Radix 6 g, Atractylodis Rhizoma 4. ",
            "cite_spans": [
                {
                    "start": 994,
                    "end": 1001,
                    "text": "Rhizoma",
                    "ref_id": null
                },
                {
                    "start": 3596,
                    "end": 3603,
                    "text": "Rhizoma",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 149,
                    "end": 157,
                    "text": "(Fig. 1)",
                    "ref_id": "FIGREF5"
                },
                {
                    "start": 320,
                    "end": 419,
                    "text": "Table 1  Herbal Medicines and Pattern Identification for Treating Mild Stage Patients With COVID-19",
                    "ref_id": null
                },
                {
                    "start": 2343,
                    "end": 2347,
                    "text": "Tang",
                    "ref_id": null
                }
            ],
            "section": "Results"
        },
        {
            "text": "No specific PI Qingfei Paidu Tang Ephedrae Herba 9 g, Glycyrrhizae Radix et Rhizoma 6 g, Armeniacae Amarum Semen 9 g, Gypsum Fibrosum 15-30 g, Cinnamomi Ramulus 9 g, Alismatis Rhizoma 9 g, Polyporus 9 g, Atractylodis Macrocephalae Rhizoma 9 g, Poria Sclerotium 15 g, Bupleuri Radix16g, Scutellariae Radix 6 g, Pinelliae Rhizoma 9 g, Zingiberis Rhizoma Recens 9 g, Asteris Radix 9 g, Belamcandae Rhizoma 9 g, Asari Herba 6 g, Dioscoreae Rhizoma 12 g, Aurantii Fructus 6 g, Citri Unshius Pericarpium 6 g, Agastachis Amarum and Ephedrae Herba were found to be the top 10 herbs with the highest frequency of use in the mild, moderate and severe stages. The Gypsum Fibrosum and Lepidii seu Descurainiae Semen were also the top 10 most common herbs used in the moderate and severe stages. In addition, Agastachis Herba, Forsythiae Fructus, Atractylodis Rhizoma, and Scutellariae Radix were also highly used in both the mild and moderate stages. Notably, Glycyrrhizae Radix et Rhizoma was found in the top 10 herbs with the highest usage frequency in all four stages. It was also the herb with the highest frequency of usage in total.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Severe"
        },
        {
            "text": "In this review, we systematically summarized and analyzed all the herbal formulae provided by the guidelines according to their pattern identification and herbal compositions. The Chinese medicine herbs used for the prevention of COVID-19 based on 23 provincial guidelines issued in mainland China were reviewed and analyzed in a recent publication. 5 With reference to it, but in contrast, our review focused on the traditional medicine treatment measures recommended by all available guidelines. We extended our search of guidelines to nearby countries and reviewed guidelines issued by mainland China (25 provincial guidelines and 1 national guideline) and South Korea to conduct a more comprehensive review.",
            "cite_spans": [
                {
                    "start": 350,
                    "end": 351,
                    "text": "5",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Discussion"
        },
        {
            "text": "For the frequency analysis of herbs used in every Chinese guideline for COVID-19, each stage has several herbs that were not shown in the list of top 10 frequently used herbs for other stages. For instance, Magnoliae Officinalis Cortex and Platycodonis Radix could only be seen for the mild stage. Magnoliae Officinalis Cortex is often prescribed for the treatment of various gastrointestinal problems, such as fullness in the stomach, vomiting, and diarrhea from dampness. Platycodonis Radix is usually prescribed for coughs with excessive phlegm and sore throat due to exogenous pathogens. 16 It could be inferred that gastrointestinal symptoms due to dampness and sore throat as well as coughing with sputum are the primary clinical manifestation in the mild stage of COVID-19. The active components contained in these 2 herbs also showed antiinflammatory benefits in the in vivo studies of the acute lung injury model. 17, 18 In the severe stage, Aconiti Lateralis Radix Praeparata and Rhei Radix et Rhizoma were identified to be frequently used but not in other stages. This could be due to the extreme PIs and clinical manifestations that are only found in severe patients. Aconiti Lateralis Radix Praeparata is known to treat heart failure and has anti-asthmatic and anti-epileptic properties. 19, 20 The combination of Aconiti Lateralis Radix Praeparata and Rhei Radix et Rhizoma is also highly compatible, and this combination is often used in various herbal formulae. As these herbs have a certain degree of toxicity, they have to be used in caution and preferably are reserved for extreme cases. 21 Moreover, there are 4 herbal medicines available only in the severe stage. Angong Niuhuang Pill, Zhi Bao Dan, Zi Xue San, and Su He Xiang Pill played a significant role in the severe stage treatment. Angong Niuhuang Pill, Zhi Bao Dan, Zi Xue San belongs to the First Aid Three Treasures of Chinese Medicine 22 , which is cold in nature and is used when the patient loses consciousness due to infectious disease-induced heat. In contrast, Su He Xiang Pill is an aromatic warm-natured medicine and is used when the patient loses consciousness due to a cold pathogen. All 4 herbal medicines were prescribed in different conditions of extremely severe or critical stages based on the patients' clinical manifestation, and they shared the same therapeutic principle to clear the orifices.",
            "cite_spans": [
                {
                    "start": 592,
                    "end": 594,
                    "text": "16",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 923,
                    "end": 926,
                    "text": "17,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 927,
                    "end": 929,
                    "text": "18",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1301,
                    "end": 1304,
                    "text": "19,",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 1305,
                    "end": 1307,
                    "text": "20",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1607,
                    "end": 1609,
                    "text": "21",
                    "ref_id": "BIBREF23"
                }
            ],
            "ref_spans": [],
            "section": "Discussion"
        },
        {
            "text": "Pinelliae Praeparatum cum Zingiberis and Citri Reticulatae Pericarpium were only identified in the list of frequently used herbs in the recovery stage where patients may suffer from white and thin phlegm after their recovery. Pinelliae Praeparatum cum Zingiberis and Citri Reticulatae Pericarpium are major components of the herbal formula Er Chen Tang, which is usually prescribed to clear phlegm and dampness. 16 Another herb, Ophiopogonis Radix, is conventionally used for nourishing yin and promoting fluid production. This herb is prescribed for dry cough caused by yin deficiency and is especially suitable for patients in the recovered stage. 16 Glycyrrhizae Radix et Rhizoma is the herb with the highest frequency use overall regardless of disease stage. It is one of the antiviral herbal medicine which is approved by the China Food and Drug Administration (SFDA). Many studies have reported that this herb inhibits viral attachment, entry and replication, which is previously used in combating SARS. 23, 24 Moreover, Glycyrrhizae Radix et Rhizoma also has an anti-inflammatory quality which is suitable for the treatment of inflammatory lung condition in COVID-19. 25 The herbal formula Qingfei Paidu Tang was recommended by both Chinese and Korean guidelines. In the Chinese guidelines, this formula is recommended for all stages. According to a recent publication, 26 this herbal formula increases immunology and reduces inflammation by targeting the lung and spleen, which are the disease pathways of COVID-19. However, the herb Farfarae Flos was removed in the Korean guidelines due to its safety and toxicity. 27 This review has several limitations. First, the results of this review were obtained after standardizing the terms of the PIs and herbal formulae. Therefore, there might be a difference in the terms used in the provided guidelines. Second, this review does not include any direct evidence on the efficacy of traditional medicine in the clinical treatment of COVID-19. The results provided by this review are a summary of the traditional medicine guidelines, which can only be considered as guidance, and clinical verification is still required. Third, although this review summarized the most recent version of the national and provincial guidelines available up to March 6, 2020, the guidelines issued on COVID-19 by the Chinese government are constantly and frequently updated.",
            "cite_spans": [
                {
                    "start": 412,
                    "end": 414,
                    "text": "16",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 650,
                    "end": 652,
                    "text": "16",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 1010,
                    "end": 1013,
                    "text": "23,",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 1014,
                    "end": 1016,
                    "text": "24",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1175,
                    "end": 1177,
                    "text": "25",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 1377,
                    "end": 1379,
                    "text": "26",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 1625,
                    "end": 1627,
                    "text": "27",
                    "ref_id": "BIBREF29"
                }
            ],
            "ref_spans": [],
            "section": "Discussion"
        },
        {
            "text": "In conclusion, this review can be used as a reference in the traditional medicine treatment of COVID-19. Clinical studies are required to evaluate the efficacy and safety of traditional medicine and to provide clinical evidence. The integration of traditional medicine into conventional treatment may be an alternative approach for the treatment of COVID-19 in the future.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Discussion"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Conceptualization: HWL and MSL. Methodology: LA and MSL. Software: LA and MSL. Validation: HWL, JYC, and JZ. Formal analysis: LA and HWL. Investigation: LA, HWL and MSL. Resources: MSL. Data curation: HWL and JYC. Writing -original draft: LA and HWL. Writing -review & editing: JYC, JZ and MSL. Visualization: HWL and MSL. Supervision: MSL",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Coronavirus Disease 2019 (COVID-19) situation summary",
            "authors": [],
            "year": 2020,
            "venue": "Centers for Disease Control and Prevention (CDC)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "WHO Director-General's opening remarks at the media briefing on COVID-19 -11",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Coronavirus map: tracking the spread of the outbreak",
            "authors": [
                {
                    "first": "Kkr",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Harris",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mccann",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Collins",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Watkins",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "World Health Organization (WHO)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [
                        "L"
                    ],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "X"
                    ],
                    "last": "Shang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "B"
                    ],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Chinese J Integr Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1007/s11655-020-3192-6"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Notice on the issuance of the new 7th version of the COVID-19 diagnosis and treatment guideline",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Announcement of the first version of Oriental Medicice Clinical Practice Guideline by the National University Network of Traditional Medicine Department of Internal Medicine",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Guidelines International Network",
            "authors": [
                {
                    "first": "G-I-N",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Chinese guidelines on Novel Coronavirus",
            "authors": [
                {
                    "first": "Evidence",
                    "middle": [],
                    "last": "Aid",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Centre for Health Protection. Department of Health. The Government of the Hong Kong Special Administrative Region",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Available from",
            "authors": [],
            "year": 2020,
            "venue": "The Japanese Respiratory Society (JRS)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Clinic terminology of traditional Chinese medical diagnosis and treatment-Syndromes",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Dictionary of traditional Chinese medicine formula",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "R"
                    ],
                    "last": "Peng",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Regional Office for the Western Pacific. WHO international standard terminologies on traditional medicine in the Western Pacific Region",
            "authors": [],
            "year": 2007,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Essentials of Chinese materia medica and medical formulas: new century traditional Chinese medicine",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Xi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "W"
                    ],
                    "last": "Gong",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Protective effects of platycodin D on lipopolysaccharide-induced acute lung injury by activating LXR\u2423-ABCA1 signaling pathway",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "Y"
                    ],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Fu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "J"
                    ],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "C"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "L"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "G"
                    ],
                    "last": "Cao",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Front Immunol",
            "volume": "7",
            "issn": "",
            "pages": "644--744",
            "other_ids": {
                "DOI": [
                    "10.3389/fimmu.2016.00644"
                ]
            }
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Magnoflorine ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-B and MAPK activation",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "F"
                    ],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "P"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Front Pharmacol",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "file:/localhost/opt/grobid/grobid-home/tmp/dx.doi.org/10.3389/fimmu.2016.00644"
                ]
            }
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Pharmacological effects of Chinese herb aconite (Fuzi) on cardiovascular system",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "D"
                    ],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "J"
                    ],
                    "last": "Cui",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "F"
                    ],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Tradit Chin Med",
            "volume": "32",
            "issn": "13",
            "pages": "60030--60038",
            "other_ids": {
                "DOI": [
                    "file:/localhost/opt/grobid/grobid-home/tmp/dx.doi.org/10.3389/fphar.2018.00982"
                ]
            }
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Pharmacokinetics of aconitine-type alkaloids after oral administration of Fuzi (Aconiti Lateralis Radix Praeparata) in rats with chronic heart failure by microdialysis and ultra-high performance liquid chromatography-tandem mass spectrometry",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "K"
                    ],
                    "last": "Xiong",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Ethnopharmacol",
            "volume": "165",
            "issn": "",
            "pages": "173--182",
            "other_ids": {
                "DOI": [
                    "file:/localhost/opt/grobid/grobid-home/tmp/dx.doi.org/10.1016/S0254-6272(13)60030-8"
                ]
            }
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Study on compatibility source of Radix Aconiti Lateralis Praeparata and Radix et Rhizoma Rhei",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Shandong Univ Trad Chinese Med",
            "volume": "30",
            "issn": "",
            "pages": "100--104",
            "other_ids": {
                "DOI": [
                    "file:/localhost/opt/grobid/grobid-home/tmp/dx.doi.org/10.1016/j.jep.2015.01.057"
                ]
            }
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "The necessity of having the \"First Aid Three Treasures of Chinese medicine\" at home",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Tong",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Chinese Health Care",
            "volume": "4",
            "issn": "",
            "pages": "21--50",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Traditional Chinese herbal medicine as a source of molecules with antiviral activity",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Antivir Res",
            "volume": "97",
            "issn": "",
            "pages": "1--9",
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2012.10.006"
                ]
            }
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "H"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "Ryt",
                    "middle": [],
                    "last": "Kao",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T"
                    ],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "W"
                    ],
                    "last": "Fan",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Clin Virol",
            "volume": "31",
            "issn": "",
            "pages": "69--75",
            "other_ids": {
                "DOI": [
                    "file:/localhost/opt/grobid/grobid-home/tmp/dx.doi.org/10.1016/j.antiviral.2012.10.006"
                ]
            }
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Study on in vitro anti-inflammatory activity of total flavonoids from Glycyrrhizae Radix et Rhizoma and its ingredients",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "L"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bian",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "D"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Zhongguo Zhong Yao Za Zhi",
            "volume": "38",
            "issn": "",
            "pages": "99--104",
            "other_ids": {
                "DOI": [
                    "file:/localhost/opt/grobid/grobid-home/tmp/dx.doi.org/10.1016/j.jcv.2004.03.003"
                ]
            }
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of Novel Coronavirus Pneumonia by network pharmacology",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "D"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Data collection of the Herbal Medicine Quality Standardization Research Group",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "The official government websites of all 31 provinces in mainland China (including municipal and autonomous regions) \u2022 The Centre for Health Protection of the Hong Kong Special Administrative Region 10 \u2022 Association of Korean Medicine and Korean Association of Traditional Pulmonary Medicine \u2022 Japanese Association for Infectious Diseases and Japanese Respiratory Society 11 \u2022 Taiwan Centers for Disease Control 12",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": ", Armeniacae Semen Amarum, Amomi Tsao-ko Fructus, Arecae Semen, Cicadae Periostracum, Forsythiae Fructus, Atractylodis Rhizoma, Platycodonis Radix, Scutellariae Radix, Arctii Semen, Glycyrrhizae Radix et Rhizoma Heat Pathogen Assailing the Lung Da Yuan Yin a Arecae Semen 10 g, Amomi Tsao-ko Fructus 10 g, Magnoliae Officinalis Cortex 10 g, Anemarrhenae Rhizoma 10 g, Scutellariae Radix 10 g, Bupleuri Radix 10 g, Paeoniae Radix Rubra 10 g, Forsythiae Fructus 15 g, Artemisiae Annuae Herba 10 g, Atractylodis Rhizoma 10 g, Isatidis Folium 10 g, Glycyrrhizae Radix et Rhizoma 5 g Ma Xing Shi Gan Tang + Da Yuan Yin Ephedrae Herba 8 g, Armeniacae Semen Amarum 10 g, Gypsum Fibrosum 30 g, Glycyrrhizae Radix et Rhizoma 10 g, Arecae Semen 10 g, Magnoliae Officinalis Cortex 10 g, Amomi Tsao-ko Fructus 10 g, Anemarrhenae Rhizoma 10 g, Paeoniae Radix 10 g, Fructus, Lonicerae Flos los, Platycodonis Radix, Menthae Herba, Arctii Semen, Lophatheri Herba, Phragmitis Rhizoma, Sojae Semen Preparatum, Ephedrae Herba, Gypsum Fibrosum, Armeniacae Semen Amarum, Bupleuri Radix, Cicadae Periostracum, Glycyrrhizae Radix et Rhizoma Ma Xing Shi Gan Tang + Xiao Chaihu Tang Ephedrae Herba 5-10 g, Armeniacae Semen Amarum 5-10 g, Gypsum Fibrosum 30-50 g, Forsythiae Fructus 10-20 g, Scutellariae Radix 5-10 g, Bupleuri Radix 10-15 g, Coicis Semen 10-15 g, Magnoliae Officinalis Cortex 5-10 g, Poria Sclerotium 10-15 g, 6 g, Armeniacae Semen Amarum 15 g, Amomi Tsao-ko Fructus 6 g, Arecae Semen 10 g, Cicadae Periostracum 10 g, Forsythiae Fructus 20 g, Atractylodis Rhizoma 10 g, Platycodonis Radix 10 g, Scutellariae Radix 15 g, Coicis Semen 20 g, Arctii Semen 15 g, Moslae Herba 12 g Huo Po Xia Ling Tang a + Yin Qiao San Agastachis Herba 15 g, Perillae Folium 15 g, Sojae Semen Preparatum 15 g, Atractylodis Rhizoma 15 g, Magnoliae Officinalis Cortex 10 g, Angelicae Decursivae Radix 15 g, Bupleuri Radix 15 g, Scutellariae Radix 10 g, Artemisiae Annuae Herba 20 g, Armeniacae Semen Amarum 10 g, Osterici seu Notopterygii Radix et Rhizoma 10 g, Lonicerae Flos 15 g, Forsythiae Fructus 15 g Ma Xing Yi Gan Tang a + Huo Po Xia Ling Tang",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Pericarpium 10-15 g, Armeniacae Semen Amarum 10-15 g, Scutellariae Radix 10-15 g, Trichosanthis Pericarpium 10-15 g, Poria Sclerotium 15-30 g, Agastachis Herba 15 g, Magnoliae Cortex 10-20 g, Artemisiae Annuae Herba 20-30 g, Phragmitis Rhizoma 20-30 g, Lonicerae Flos 15-30 g, Pseudostellariae Radix 30 g, Glycyrrhizae Radix et Rhizoma 5-10 g Ma Xing Shi Gan Tang + Ganlu Xiaodu Dan + Sheng Jiang San Ephedrae Herba 5-10 g, Armeniacae Semen Amarum 5-10 g, Gypsum Fibrosum 30-50 g, Talcum 10-20 g, Artemisiae Scopariae Herba 10-30 g, Scutellariae Radix 10-15 g, Amomi Fructus Rotundus 5-10 g, Agastachis Herba 10-15 g, Atractylodis Rhizoma 10-15 g, Lepidii seu Descurainiae Semen 10-20 g, Forsythiae Fructus 10-15 g, Batryticatus Bombyx 5-10 g, Cicadae Periostracum 6-12 g, Curcumae Longae Rhizoma 5-10 g, Paeoniae Rubra Radix 10-15 g, Glycyrrhizae Radix et Rhizoma 5",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "15 g, Gypsum Fibrosum 15-20 g, Pseudostellariae Radix 20-30 g, Ophiopogonis Radix 10-15 g, Pinelliae Rhizoma 10 g, Atractylodis Macrocephalae Rhizoma 15-20 g, Poria Sclerotium 15-20 g, Glycyrrhizae Radix et Rhizoma 5-10 g Zhuye Shigao Tang Lophatheri Herba, Gypsum Fibrosum, Pseudostellariae Radix, Ophiopogonis Radix, Pinelliae Rhizoma, Oryzae Semen, Phragmitis Rhizoma, Setariae Fructus Germinatus, Glycyrrhizae Radix et Rhizoma No specific PI",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Semen 10 g, Gypsum Fibrosum 20 g, Glycyrrhizae Radix et Rhizoma 10 g, Phragmitis Rhizoma 20 g, Benincasae Pericarpium 15 g, Coicis Semen 20 g, Persicae Semen 10 g, Trichosanthis Pericarpium 10 g, Scutellariae Radix 10 g, Pinelliae Rhizoma 10 g, Rhei Radix et Rhizoma 5-10 g, Paeoniae Radix 10 g, Aurantii Fructus Immaturus 10 g, Arecae Semen 10 g, Lepidii seu Descurainiae Semen 15 g, Perillae Folium 10 g, Platycodi Radix 10 g, Anemarrhenae Rhizoma 10 g Ma Xing Shi Gan Tang + Qing qi Huatan Tang Ephedrae Herba 9 g, Armeniacae Semen 10 g, Gypsum Fibrosum 30-50 g, Glycyrrhizae Radix et Rhizoma 10 g, Fritillariae Thunbergii Bulbus 15 g, Trichosanthis Fructus 15 g, Scutellariae Radix 15 g, Platycodi Radix 15 g, Aurantii Fructus Immaturus 15 g, Poria Sclerotium 20 g, Lepidii seu Descurainiae Semen 15 g, Houttuyniae Herba 30 g, Atractylodis Rhizoma Alba 15 g, Atractylodis Rhizoma 15 g, Citri Reticulatae Pericarpium 10 g, Pinelliae Rhizoma 10 g Dampness Huoxiang Zhengqi San Agastachis Herba 6 g, Perillae Folium 4 g, Angelicae Dahuricae Radix 2 g, Arecae Pericarpium 2 g, Poria Sclerotium 2 g, Magnoliae Cortex 2 g, Atractylodis Rhizoma Alba 2 g, Citri Unshius Pericarpium 2 g, Pinelliae Tuber 2 g, Platycodi Radix 2 g, Glycyrrhizae Radix et Rhizoma 2 g, Zingiberis Rhizoma Crudus 4 g, Zizyphi Fructus 4 g Huo Po Xia Ling Tang Coicis Semen 16 g, Poria Sclerotium 12 g, Armeniacae Semen 12 g, Glycine Semen Preparatum 12 g, Agastachis Herba 8 g, Pinelliae Tuber 6 g, Polyporus 6 g, Alismatis Rhizoma 6 g, Magnoliae Cortex 4 g, Amomi Fructus Rotundus 2.4 g Da Yuan Yin Arecae Semen 10 g, Amomi Tsao-ko Fructus 10 g, Magnoliae Cortex 10 g, Anemarrhenae Rhizoma 10 g, Scutellariae Radix 10 g, Bupleuri Radix 10 g, Paeoniae Radix Rubra 10 g, Forsythiae Fructus 15 g, Artemisiae Annuae Herba 10 g, Atractylodis Rhizoma 10 g, Isatidis Folium 10 g, Glycyrrhizae Radix et Rhizoma 5 g Yin Qiao San + San Ren Tang Lonicerae Flos 15 g, Forsythiae Fructus 15 g, Platycodi Radix 10 g, Arctii Semen 10 g, Phragmitis Rhizoma 20 g, Menthae Herba 10 g, Armeniacae Semen 10 g, Amomi Fructus Rotundus 6 g, Coicis Semen 20 g, Tetrapanacis Medulla 10 g, Paeoniae Radix 10 g, Pinelliae Rhizoma 10 g, Talcum 20 g, Arecae Semen 10 g, Amomi Tsao-ko Fructus 5 g, Scutellariae Radix 10 g, Glycyrrhizae Radix et Rhizoma 5",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Frequency of commonly used herbs in the herbal formulae for treating patients with COVID-19 in (A) mild stage; (B) moderate stage; (C) severe stage; (D) recovery stage; (E) total frequency of all stages.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Coptidis Rhizoma, Magnoliae Officinalis Cortex, Pinelliae Rhizoma Praeparatum, Agastachis Herba, Poria Sclerotium, Polyporus, Talcum, Amomi Fructus Rotundus, Armeniacae Semen Amarum, Coicis Semen, Tetrapanacis Medulla, Alismatis Rhizoma No specific PI",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Herbal Medicines and Pattern Identification for Treating Moderate Stage Patients With COVID-19 Ephedrae Herba, Armeniacae Semen Amarum, Gypsum Fibrosum, Mori Radicis Cortex, Lonicerae Flos, Forsythiae Fructus, Scutellariae Radix, Fritillariae Pallidiflorae Bulbus, Glycyrrhizae Radix et Rhizoma, Phragmitis Rhizoma Ephedrae Herba, Armeniacae Semen Amarum, Gypsum Fibrosum, Lonicerae Flos, Forsythiae Fructus, Scutellariae Radix, Curcumae longae Radix, Fritillariae Thunbergii Bulbus, Paeoniae Rubra Radix, Arisaematis Rhizoma Preparata cum Bovis Fel, Rhei Rhizoma Preparata cum Vinum, Coicis Semen Ma Xing Shi Gan Tang a + Ganlu Xiaodu Dan + Sangbaipi Yin",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Xuan Bai Cheng Qi Tang + Huanglian Jiedu Tang Ephedrae Herba, Armeniacae Semen Amarum, Gypsum Fibrosum, Arisaematis Rhizoma Preparata cum Bovis Fel, Rhei Rhizoma Preparata cum Vinum, Lepidii seu Descurainiae Semen, Bubali Cornu, Persicae Semen, Paeoniae Rubra Radix, Hirudo, Coicis Semen, Glycyrrhizae Radix et Rhizoma Ma Xing Shi Gan Tang Ephedrae Herba 10 g, Gypsum Fibrosum 30 g, Armeniacae Semen Amarum 10 g, Glycyrrhizae Radix et Rhizoma 6 g, Trichosanthis Fructus 30 g, Rhei Radix et Rhizoma 6 g, Lepidii seu Descurainiae Semen 30 g, Perillae Folium 30 g, Amomi Tsao-ko Fructus 6 g, Arecae Semen 6 g, Atractylodis Rhizoma 10 g Bai Hu Tang + Qingying Tang + Qingwen Baidu Yin Gypsum Fibrosum 30 g, Scrophulariae Radix 20 g, Rehmanniae Radix 15 g, Moutan Cortex Radicis 15 g, Lophatheri Herba 10 g, Lonicerae Flos 15 g, Forsythiae Fructus 15 g, Scutellariae Radix 15 g, Menthae Herba 20 g, Paeoniae Rubra Radix 15 g, Curcumae longae Radix 15 g, Lepidii seu Descurainiae Semen 10 g, Glycyrrhizae Radix et Rhizoma 10 g Ma Xing Shi Gan Tang + Yin Qiao San Ephedrae Herba 9 g, Armeniacae Semen Amarum 9 g, Gypsum Fibrosum 30 g, Mori Radicis Cortex 15 g, Lonicerae Flos 20 g, Forsythiae Fructus 15 g, Scutellariae Radix 12 g, Fritillariae Thunbergii Bulbus 15 g, Glycyrrhizae Radix et Rhizoma 9 g, Dendrobii Herba 15 g, Panacis Quinquefolii Radix 15 g Ephedrae Herba, Armeniacae Semen Amarum, Gypsum Fibrosum, Mori Radicis Cortex, Lonicerae Flos, Forsythiae Fructus, Scutellariae Radix, Fritillariae Thunbergii Bulbus, Glycyrrhizae Radix et Rhizoma Ephedrae Herba 10 g, Armeniacae Semen Amarum 10-15 g, Gypsum Fibrosum 20-30 g, Mori Radicis Cortex 15 g, Lonicerae Flos 20-30 g, Forsythiae Fructus 20-30 g, Scutellariae Radix 15 g, Fritillariae Thunbergii Bulbus 15 g, Glycyrrhizae Radix et Rhizoma 5-10 g No specific PI",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Herbal medicines and pattern identification for treating severe stage patients with COVID-19 Ginseng Radix 15 g, Aconiti Lateralis Radix Praeparata 10 g, Corni Fructus 15 g, Su He Xiang Pill/Angong Niuhuang Pill Shen Fu Tang a + Su He Xiang Pill/Angong Niuhuang Pill/Zi Xue San Ginseng Radix 15 g, Aconiti Lateralis Radix Praeparata 10 g, Corni Fructus 15 g, Su He Xiang Pill/Angong Niuhuang Pill/Zi Xue San Shen Fu Tang + Su He Xiang Pill/Angong Niuhuang Pill/Shexiang Niuhuang Pill Ginseng Radix 15 g, Aconiti Lateralis Radix Praeparata 10 g, Corni Fructus 15 g, Su He Xiang Pill/Angong Niuhuang Pill/Shexiang Niuhuang Pill Shen Fu Tang Panax ginseng Radix, Aconiti Lateralis Radix Praeparata, Asparagi Radix, Ophiopogonis Radix, Rhei Radix et Rhizoma, Lonicerae Flos, Bubali Cornu, Corni Fructus, Schisandrae Fructus, Phragmitis Rhizoma, Glycyrrhizae Radix et Rhizoma a Ginseng Radix 15 g, Aconiti Lateralis Radix Praeparata 10 g, Acori Tatarinowii Rhizoma 10 g, Curcumae longae Radix 10 g, Corni Fructus 10 g, Schisandrae Fructus 10 g, Zingiberis Rhizoma 15 g, Glycyrrhizae Radix et Rhizoma 10 g Sheng Mai San + San Shi Tang + Angong Niuhuang Pill Panaciis Quinquefolii Radix, Ophiopogonis Radix, Schisandrae Fructus, Gypsum Rubrum, Talcum, Gypsum Fibrosum, Armeniacae Semen Amarum, Lonicerae Flos, Tetrapanacis Medulla, Bambusae Caulis in Taeniam, Angong Niuhuang Pill Si Ni Jia Renshen Tang + Angong Niuhuang Pill/Zi Xue San 1. Ginseng Radix 15 g, Aconiti Lateralis Radix Praeparata 15 g, Corni Fructus 20 g, Angong Niuhuang Pill/Zi Xue San 2. Ginseng Radix 5-10 g, Aconiti Lateralis Radix Praeparata 6-10 g, Corni Fructus 20-25 g, Angong Niuhuang Pill/Zi Xue San 3. Ginseng Radix, Aconiti Lateralis Radix Praeparata, Corni Fructus, Bambusae Silicea Concretio, Angong Niuhuang Pill/Zi Xue San Si Ni Jia Renshen Tang + Zhi Xue San / Su He Xiang Pill/Angong Niuhuang Pill Panax ginseng Radix 20-30 g, Aconiti Lateralis Radix Praeparata 30-60 g, Corni Fructus 15-20 g, Zhi Xue San, Su He Xiang Pill/Angong Niuhuang Pill Ephedrae Herba, Armeniacae Semen Amarum, Gypsum Fibrosum, Mori Radicis Cortex, Fritillariae Thunbergii Bulbus, Glycyrrhizae Radix et Rhizoma Xuan Bai Cheng Qi Tang + Sang Bei San Armeniacae Semen Amarum, Gypsum Fibrosum, Trichosanthis Fructus, Rhei Radix et Rhizoma, Mori Radicis Cortex, Fritillariae Thunbergii Bulbus (Self-prescribed) Tingli Xiefei TangLepidii seu Descurainiae Semen 15 g, Trichosanthis Fructus 9 g, Fagopyri Radix 30 g, Tripterospermi Chinensis Herba 30 g, Scutellariae Radix 30 g, Perillae Fructus 9 g, Allii Macrostemi Bulbus 12 g, Pinelliae Praeparatum cum Zingiberis 12 g, Cinnamomi Ramulus 9 g, Paeoniae Radix Alba 15 g, Chuanxiong Rhizoma 15 g, Brassicae Semen 9 g Shen Fu TangGinseng Radix Rubra 10 g, Aconiti Lateralis Radix Praeparata 10 g, Corni Fructus 30 g, Ophiopogonis Radix 20 g, Notoginseng Radix 10 g",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Continued)",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "Herbal Medicines and Pattern Identification for Treating Recovery Stage Patients With COVID-19 Codonopsis Radix 10 g, Poria Sclerotium 15 g, Atractylodis Macrocephalae Rhizoma 10 g, Citri Reticulatae Pericarpium 10 g, Bambusae Caulis in Taeniam 10 g, Glehniae Radix 15 g, Ophiopogonis Radix 10 g, Schisandrae Fructus 6 g, Albizziae Cortex 15 g, Setariae Fructus Germinatus 15 g, Hordei Fructus Germinatus 15 g, Glycyrrhizae Radix et Rhizoma 6 g Buzhong Yiqi Tang a + Shashen Maidong Tang Astragali Radix 15 g, Pseudostellariae Radix 15 g, Lophatheri Herba 15 g, Adenophorae Radix 15 g, Ophiopogonis Radix 15 g, Phragmitis Rhizoma 20 g, Trichosanthis Radix 9 g, Polygonati Odorati Rhizoma 6 g, Imperatae Rhizoma 20 g, Glycyrrhizae Radix et Rhizoma 10 g Maiwei Buzhong Yiqi Tang Pseudostellariae Radix, Ophiopogonis Radix, Schisandrae Fructus, Astragali Radix, Atractylodis Macrocephalae Rhizoma, Citri Reticulatae Pericarpium, Angelicae Sinensis Radix, Glehniae Radix, Armeniacae Semen Amarum, Eriobotryae Folium, Lilii Bulbus, Glycyrrhizae Radix et Rhizoma Shengmai San Pseudostellariae Radix 15 g, Ophiopogonis Radix 30 g, Schisandrae Fructus 10 g, Astragali Radix 30 g, Atractylodis Macrocephalae Rhizoma 20 g, Citri Reticulatae Pericarpium 10 g, Angelicae Sinensis Radix 15 g, Glehniae Radix 15 g, Armeniacae Semen Amarum 10 g, Glycyrrhizae",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "15 g, Setariae Fructus Germinatus 15 g Spleen-Lung Qi Deficiency Buzhong Yiqi Tang + Caihu Sugan San Ginseng Radix Rubra, Astragali Radix praeparata cum melle, Citri Reticulatae Pericarpium, Angelicae Sinensis Radix, Bupleuri Radix, Platycodonis Radix, Corni Fructus, Amomi Fructus, Atractylodis Macrocephalae Rhizoma, Polygoni Multiflori Radix, Coicis Semen Huangqi Liu Junzi Tang",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "Continued) Bufei Tang + San Zi Yangqin Tang Astragali Radix 15 g, Pseudostellariae Radix 15 g, Corni Fructus 15 g, Aurantii Immaturus Fructus 10 g, Perillae Fructus 10 g, Brassicae Semen 10 g, Schisandrae Fructus 10 g, Persicae Semen 10 g, Carthami Flos 10 g Shashen Maidong Tang Adenophorae Radix 15 g, Ophiopogonis Radix 15 g, Polygonati Odorati Rhizoma 10 g, Lablab Semen Album 20 g, Mori Folium 10 g, Trichosanthis Radix 20 g, Glycyrrhizae Radix et Rhizoma 6 g Shengmai Yin a + Maimendong Tang Pseudostellariae Radix/Panacis Quinquefolii Radix 15 g, Ophiopogonis Radix 18 g, Schisandrae Fructus 9 g, Pinelliae Rhizoma Praeparatum 9 g, Citri Reticulatae Pericarpium 9 g, Poria Sclerotium 15 g, Fructus Amomi 6 g, Lablab Semen Album 15 g Dual Damage of Qi and Fluid Shengyang Yiwei Tang + Zhuye Shigao Tang + Xiao Chaihu Tang) + Buzhong Yiqi Tang + Shengmai Yin",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "",
            "latex": null,
            "type": "table"
        },
        "TABREF9": {
            "text": "Shen Fu Tang + Su He Xiang Pill Ginseng Radix 15 g, Aconiti Lateralis Radix Praeparata 10 g, Corni Fructus 15 g, Su He Xiang Pill Recovery No specific PI Shen Zhu Jianpi Tang + Shengmai San Liriopis Tuber 8 g, Ginseng Radix 4 g, Atractylodis Rhizoma Alba 4 g, Poria Sclerotium 4 g, Crataegi Fructus 4 g, Citri Unshius Pericarpium 4 g, Magnoliae Cortex 4 g, Schisandrae Fructus 4 g, Paeoniae Radix 3.2 g, Ponciri Fructus Immaturus 3.2 g, Glycyrrhizae Radix et Rhizoma 2 g, Hordei Fructus Germinatus 2 g, Amomi Fructus 2 g, Massa Medicata Fermentata 2 g, Zingiberis Rhizoma Crudus 4 g, Zizyphi Fructus 4 g No specific PI Shen Zhu Jianpi Tang + Qingshu Yiqi Tang Atractylodis Rhizoma 6 g, Poria Sclerotium 4 g, Atractylodis Rhizoma Alba 3 g, Crataegi Fructus 4 g, Ginseng Radix 3 g, Citri Unshius Pericarpium 3 g, Magnoliae Cortex",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "The authors thank the American Journal Experts for offering free editing services for this paper as an article on COVID-19.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Acknowledgment"
        },
        {
            "text": "The authors declare no conflict of interest.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conflict of interest"
        },
        {
            "text": "This study was supported by the Korea Institute of Oriental Medicine (KSN2013210).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Funding"
        },
        {
            "text": "This research did not involve any human or animal experiment.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Ethical statement"
        },
        {
            "text": "Data will be made available upon reasonable request.Supplementary Table S1. English and Chinese terms of pattern identification, herbal formulae and herbs name can be found in the online version, at https://doi.org/10.1016/j.imr.2020.100407.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data availability"
        }
    ]
}